But in your words, what have been some of the biggest findings and things that you think you've been able to develop across the course of your career?

So I think I would pick two things.

And it's funny because the first one is the same as Rachel.

The first one summarizes 25 years for me of concerns around pregnancy planning and how to manage MS in those periods of life.

And it is, of course, our work published last year in Neurology done on the French MS registry data, which is called OFSAP, and showing that women with MS have less chances to receive a DMT than men.

taken into account or correcting for disease activity, severity, and after excluding the pregnancy year where, of course, women are less exposed to DMTs.

And the study also showed that the difference is even more important with highly active DMTs, which is a pity.

Sandra, yeah, please.